Chengli Du
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
-
- Lung Cancer Diagnosis and Treatment 8
- Pleural and Pulmonary Diseases 3
Chengli Du
31 papers receiving 999 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 509
- Molecular Biology 719
- Oncology 236
- Pulmonary and Respiratory Medicine 143
- Immunology 79
Countries citing papers authored by Chengli Du
This map shows the geographic impact of Chengli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengli Du more than expected).
Fields of papers citing papers by Chengli Du
This network shows the impact of papers produced by Chengli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengli Du. The network helps show where Chengli Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengli Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 41 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 19 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 102 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 28 | |
| 17 | 2015 | 61 | |
| 18 | 2014 | 110 | |
| 19 | 2014 | 41 | |
| 20 | 2014 | 17 |
About Chengli Du
Chengli Du is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Internal Medicine, Molecular Biology and Oncology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (8 papers), RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), Pleural and Pulmonary Diseases (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Cancer Research (509 citations), Molecular Biology (719 citations), Oncology (236 citations), Pulmonary and Respiratory Medicine (143 citations) and Immunology (79 citations). Chengli Du has collaborated with scholars based in China, Madagascar and Chile. Frequent co-authors include Haiyang Xie, Shusen Zheng, Jian Wu, Chaofeng Ding, Zhen Lv, Heng Xiao, Shaobing Cheng, Lin Zhou, Chuanhui Peng and Lin Zhou. Their work appears in journals such as Annals of Translational Medicine, Cancer Letters, International Journal of Molecular Sciences, Oncotarget and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.